Genomic and biomarker data are complex and are not consistently converted into clear, patient-specific diagnostic or treatment decisions.
R&D Focus
ViewsML uses AI for virtual diagnostics, enhancing precision medicine and spatial biology with virtual biomarkers
Innovative Solution
ViewsML leverages artificial intelligence to enhance virtual diagnostics and precision medicine. The company focuses on transforming spatial biology and translational research by utilizing virtual biomarkers.
Investment Funding
Last Funding Stage
Pre-Seed
Last Funding Date
14-06-2024
Startup Stage
Seed
Lead Investors
RiSC Capital
Revenue
$1M to $10M
People
Founders
Kenneth To
Rafay Azhar
About
ViewsML leverages artificial intelligence to enhance virtual diagnostics and precision medicine. The company focuses on transforming spatial biology and translational research by utilizing virtual biomarkers. Their technology aims to improve patient outcomes by providing deeper insights into healthcare diagnostics. ViewsML is involved in developing immunohistochemistry technology to streamline the diagnostic process and support research objectives efficiently.
Products
Demo Product or Complete Product?
Development stage
Something missing or incorrect on this page? Help us enrich this information
